Literature DB >> 20567496

Notch and Wnt signaling, physiological stimuli and postnatal myogenesis.

Susan Tsivitse1.   

Abstract

Adult skeletal muscle stem cells, termed satellite cells are imperative to muscle regeneration. Much work has been performed on satellite cell identification and the subsequent activation of the myogenic response but the regulation of satellite cells including its activation is not well elucidated. The purpose of this review article is to synthesize what the literature reveals in regards to the current understanding of satellite cells including their contribution to muscle repair and growth following physiological stimuli. In addition, this review article will describe the recent findings on the roles of the classic developmental signaling pathways, Notch and Wnt, to the myogenic response in various muscle injury models. This purpose of this summary is to bring awareness of the impact that muscle contraction models have on the local and systemic environment of adult muscle stem cells which will be beneficial for comprehending and treatment development for muscle -associated ailments and other organ diseases.

Entities:  

Keywords:  Notch and Wnt; muscle repair and growth; physiological stimuli

Mesh:

Year:  2010        PMID: 20567496      PMCID: PMC2878172          DOI: 10.7150/ijbs.6.268

Source DB:  PubMed          Journal:  Int J Biol Sci        ISSN: 1449-2288            Impact factor:   6.580


Introduction

Since the identification of satellite cells on skeletal muscle fibers in 19611, the field of satellite cell biology has progressed immensely to its recent characterization as an adult stem cell and its implications in regenerative medicine. Although portrayal of postnatal myogenesis predominates the satellite cell biology field, what is less known is/are the factor(s) responsible for satellite cell activation and the myogenic response. In addition, there is no confirmation on the overall importance of satellite cells to muscle repair and growth following physiological stimuli. In recent years, Notch and Wnt signaling have been determined to be critical for postnatal myogenesis but limited muscle regeneration models have been utilized to test these pathways 2-6. Employing a variety of muscle injury and growth techniques will result in a definitive understanding of satellite cell contribution to muscle repair and hypertrophy. With its systemic effects, physiological stimuli are an ideal muscle model as relates to investigating the myogenic properties of muscle regeneration and growth including satellite cell activation. Although the amount of muscle injury induced may not be as profound as artificial models, contraction-induced muscle injury and muscle overloading exercises are identified to up-regulate myogenic proteins. This review will summarize the literature to address the interest on the effects of physiological stimuli on Notch and Wnt signaling pathways during postnatal myogenesis. We will discuss the current knowledge on satellite cell regulation as well as the recent developments of the importance of Notch and Wnt signaling to muscle repair. We will also examine the usefulness of physiological stimuli to studying the regulation of satellite cell activation and muscle regeneration. Furthermore, we will enlighten the reader with what is currently known on the effects of physiological stimuli and muscle repair as relates to Notch and Wnt signaling.

The role of satellite cells during muscle regeneration

Skeletal muscle has the remarkable capability to completely repair within a few weeks of an insult 7. Immediately following exposure to overt skeletal muscle injury (injurious contractions, chemical, freeze and crush), muscle degeneration occurs including ultrastructural damage to the contractile apparatus such as z-line streaming, A-band disruption, and altered sarcomere length 8, 9. In addition, disruptions to the sarcolemma and increased cellular permeability renders the muscle fiber to be susceptible to the autogenetic response via activation of the non-lysosomal calpain system which further disrupts the contractile apparatus 10, 11. In the hours to days following the initial mechanical injury, the acute inflammatory response is initiated within the injured muscle fiber and is characterized by vasodilation of the microcirculation, increased permeability of proteins accumulation and infiltration of phagocytes (neutrophils, monocytes and macrophages) 12. Chemotactic signals derived from the muscle itself, resident muscle macrophages or the circulatory system direct the inflammatory cells to the injured site within the muscle fiber in which they function to destroy the necrotic tissue and prepare the site for muscle regeneration 13, 14. The muscle regeneration process in postnatal skeletal muscle is mostly attributed to the small population of myogenic stem cells termed satellite cells. Located beneath the myofiber basal lamina, quiescent satellite cells comprise a small percentage of myonuclei (~5% at two months of age) 15. Quiescent satellite cells are mitotically arrested at G0 state and are characterized with small cytoplasm, condensed chromatin and flatten shape 15. Satellite cells have often been identified to be Pax 7+, CD34+, CD45- and Sca1- 16. However, there are several markers identified to be associated with quiescent satellite cells such as CD34, α7-integrin, Pax-7, ABGC2, MCadherin, Syndecan 3/4, c-met, Cdh15, Foxk1 (formerly myocyte nuclear factor), Pax3, Sox8, Sox15, Vcam1, CXCR4, β1 integrin, and SM/C-2.6 antibody, calcitonin receptor, Caveolin-1and sphingomyelin 15, 17-26. It is improbable to identify a single marker discriminating quiescent satellite cells from proliferating myogenic precursor cells since many of the aforementioned markers may only identify specific subpopulations of satellite cells or stage of satellite cell activation. Following muscle injury, quiescent satellite cells are exposed to signals derived either from the damaged muscle or elsewhere within the injured microenvironment and the cells become activated. Many factors have been suggested to be responsible for activation of satellite cells, such as muscle-derived growth factors including hepatocyte growth factor, fibroblast growth factor 2, 6, cytokines such as interleukin-6, heat stress, and developmental signaling pathways, but the molecular/cell mechanisms leading to awakening of satellite cells and from the unperturbed state remain to be fully identified 2, 7, 27, 28. Upon activation, satellite cells undergo increased cytoplasmic volume, decreased heterochromatin and they become mitotically active as they transition from G0 to G1 cell cycle phase. Once in the first cycle satellite cells enter an intermediate progenitor stage and are known as myogenic precursor or progenitor cells 15. Within hours following activation, satellite cells up regulate the expression of basic helix-loop-helix transcriptional activators of the myogenic regulatory factor (MRF) family (MyoD, Myf5) and progress to the highly proliferative phase termed myoblasts. MRFs are essential for muscle regeneration. MyoD (-/-) null mice and mice with either double-knockout for MyoD and Myf5 genes or triple mutant of Myf5, Mrf4 and MyoD demonstrate a complete loss of skeletal muscle formation 29-32. In the days post activation, proliferating myoblasts express the cell cycle arrest protein, p21 and late MRFS (Myogenin and MRF4), resulting in withdrawal from the cell cycle and initiation of terminal differentiation to form multinucleated myotubes. Completion of the differentiation program results in fusion of myotubes with each other or with existing myofibers and is often identified with increased expression of muscle specific Myosin Heavy Chain (MHC). Myogenin has been identified to be critical for myoblast differentiation as demonstrated in myogenin-deficient embryos that have myoblasts but not myofibers due to defective myotube formation 33, 34. MicroRNAs (miRs), which function in post-transcriptional modification have recently been identified to participate in skeletal muscle repair and may play a role in the transition of proliferation to differentiation state of myoblasts 35, 36. Exogenous application of miR1, miR-133 and miR-206 to lacerated rat TA result in enhanced muscle repair including increased expression of MyoD and Pax7 35. In embryos, miR-27b targets and down-regulates Pax3 thereby promoting differentiation while miR-27b inhibitors result in continual Pax3 expression and proliferation of satellite cells 36. These data suggest that microRNAs may provide a novel strategy for understanding the regulation of skeletal muscle repair particularly as relates to the transition of myoblast proliferation to the differentiation stage. The importance of Pax 7 as relates to MRFs and postnatal myogenesis is a prevalent study topic in satellite cell biology. Upon activation and proliferation of satellite cells, Pax 7 has been identified to up regulate MyoD through the recruitment of histone methyltransferase complex 37, 38 and as myoblasts progress to the differentiation stage, Pax 7 expression is down regulated 39. However, there is also a small population of activated satellite cells that retain Pax 7 expression and do not express MyoD or Myf5. These cells function to maintain the progenitor pool by returning to a quiescent state instead of committing to myogenic differentiation 38, 39. The importance of Pax 7 to muscle regeneration may end by 21 days of age in rodents 32, 40. Lepper et al. 40 tracked the temporal fate of inactive Pax7 gene expression and reports that in adult mice with mutant Pax 7, myogenesis was able to ensue 40. Therefore, Pax 7 may be critical for satellite cell activation up to a “juvenile age” in which young skeletal muscle is developed and the remaining satellite cells are not needed and go into quiescence. There is much evidence supporting the notion that satellite cells possess stem cell properties such as their ability to generate non-muscle lineages. Satellite cells migrated from single muscle fibers cultured on Matrigel formed myoblasts and myotubes but also expressed osteogenic and adipogenic protein markers suggesting that satellite cells have the potential to convert to other mesodermal derivatives including osteocytes and adipocytes 41. Myoblasts treated with bone morphogenic protein (BMPs) differentiate into osteocytes and suppress the expression of MRFs such as MyoD 42, 43. In addition, myoblasts convert to adipocytes when cultured with thiazolidinedione or fatty acids 44. C2C12s engineered for expression of CCAAT/enhancer-binding proteins (C/EBPs) (adipogenic protein) or BMPs (osteogenic protein) result in differentiation of each respective fate 45. MyoD (-/-) null mice are not more susceptible to transition to osteogenic or adipogenic fates when treated with BMP or thiazolidinedione respectively relative to control mice suggesting that MyoD is not critical for possession of a myogenic fate 41. In vivo models also show the conversion of muscle to non-myogenic lineages including the presence of adipose tissue and bone formation within muscle diseases such as Duchenne Muscular Dystrophic patients and mdx mice 30, 46-54. Another unique stem cell characteristic of satellite cells are their ability to self renew 20, 22, 55-59. It has been suggested that a small population of activated satellite cells do not proliferate but assist in maintaining the quiescent satellite cell pool to ensure enough satellite cells are present for repairing of injured skeletal muscle 20, 22, 55-57. Transplantation of genetically-labeled myofibers into mdx mice that were depleted of satellite cells result in replenishment of the satellite cell pool 58. There are multiple mechanisms for self-renewal. Activated satellite cells have been demonstrated to divide into 2 separate satellite cell populations, one faction that rapidly divides and another group that divides at a slower rate and may have the duty of replenishing the satellite cell pool 59. Self-renewal may also occur through asymmetric division in which a daughter cell does not further divide and maintains stem-cell properties including expression of Sca1, Notch1and Pax7 while the other daughter cell proliferates and progresses down the myogenic lineage by expressing the muscle differentiation marker Desmin 2, 60-65. Notch inhibitor, Numb is asymmetrically expressed on the activated satellite cells and may regulate cell fate choices by promoting progression down the myogenic lineage 2. Self renewal may also occur through symmetrical division in which both daughter cells maintain stem-cell properties 66, 67. Cells that do not express MyoD but continue to express Pax 7 are suggested to be refrained for self-renewal 32. There is great advancement in postnatal myogenesis characterization as well as the recognition of the stem cell properties of satellite cells including their tactics to maintaining their numbers. The factors responsible for satellite cell regulation are under study and need to be determined. Ascertaining satellite cell regulation will have implications in muscle -associated ailments and disease as well as implications in stem-cell regenerative medicine.

The role of Notch and Wnt in muscle regeneration

Notch and Wnt signaling are well known to play a critical role in determining tissue specificity of stem cells by regulating cell fate decisions during embryonic development 68-72. Since satellite cells are stem cells it is plausible to infer that Notch and Wnt are important for postnatal myogenesis. Activation of Notch signaling occurs when the transmembrane Notch receptor interacts with one of its cell-membrane-anchored DSL ligands (Delta/Jagged, Serrate, or Lag2) and undergoes a series of cleavages from metalloproteases and γ-secretases resulting in the intercellular domain of Notch (NICD) translocating to the nucleus (Figure 1). Within the nucleus, the now active NICD interacts with transcriptional repressors of the CSL family (CBF1/RBP-J, Suppressor of Hairless (Su[H]), and Lag-1) and converts them to transcriptional activators (NICD-CSL). With involvement of other proteins, the CSL-NICD complex regulates target genes such as Hey and Hes genes, which encode proteins known to be involved in myogenesis 68.
Figure 1

Notch signaling pathway.

Within hours to days following muscle injury there is increased expression of Notch signaling components (Delta-1, Notch-1 and active Notch) on activated satellite cells and neighboring muscle fibers2, 3. Up-regulation of Notch signaling promotes the transition of activated satellite cells to highly proliferative myogenic precursor cells and myoblasts, as well as prevents myoblast differentiation to myotubes 3-6, 73, 74. Myoblast proliferation is decreased and differentiation is promoted when Notch activity is inhibited in myoblasts with Notch antagonist, Numb,γ-secretase inhibitor, or with small-interfering RNA (siRNA) knockdown of Presenilin-1 2, 4, 75-78. In addition, mutations in Delta-like 1 or CSL result in excessive premature muscle differentiation and defective muscle growth 79, 80. Multiple mechanisms for how Notch signaling prevents myoblast differentiation have been proposed 81-87. Hes1 or Hey1 may form a complex with MyoD to repress its expression resulting in inhibiting critical proteins for myotube formation such as Mef2D and Myogenin 6, 81-83, 88, 89. However, a recent study by Buas et al. 84 does not show an interaction with Hey1 and MyoD and instead proposes that Hey1 prevents MyoD to bind to Myogenin or Mef2C promoters thereby inhibiting their transcription and ultimately repressing muscle differentiation84. Another mechanism for Notch preventing differentiation is a potential cooperative effort between Notch and other signaling pathways to allow for sufficient myoblast proliferation prior to differentiation 85, 86. Forkhead Box O 1 transcription factor (FOXO1) prevents muscle differentiation and is suggested to be critical for downstream Notch signaling since siRNA-induced inhibition of FOXO1 represses Notch-induced Hes1 activity in C2C12 cells 85. FOXO1 interacts with CSL of Notch resulting in up regulation of Hes1 promoter activity. In addition, Transforming Growth Factor ß signaling pathway (TGFß) induces Hes1 expression in C2C12 cells which may lead to inhibition of MyoD and progression of muscle differentiation 86, 87. Similar to Notch, canonical Wnt signaling is critical for muscle repair 90-94. The canonical Wnt signaling cascade entails soluble Wnt ligands to interact with Frizzled receptors and low-density lipoprotein receptor-related protein co-receptors (LRP) (Figure 2). This coordination stimulates phosphorylation of Disheveled and inactivates GS3Kß's phosphorylation of ß catenin. With the assistance of Axin, the de-phosphorylated and stable ß- catenin does not undergo ubiquitination and degradation and is instead translocated to the nucleus where it binds to TCF/LEF1 transcription factors 95. TCF/LEF1 transcription factors may directly activate MyF5 and MyoD or may up regulate MRF co-activators such as c-Jun N-terminal kinases 96-98.
Figure 2

Canonical Wnt signaling pathway.

There is a preponderance of evidence demonstrating that skeletal muscle injury up regulates Wnt signaling 90-94. mRNA expression of Wnts5a, 5b, 7a, and 7b increases in muscle at four days post cardiotoxin-induced injury 90. At four days post myofiber explantation, there is elevated expression of Wnt3a, Frizzled1 and 2, and Axin2 93. Using TCF-optimal promoter B-galactosidase mice (TOPGAL mice) there is increased TCF reporter activity in myogenic cells at two and five days post freeze-induced muscle injury 93. Furthermore, differentiating myoblasts express Wnt signaling co-activator BCL9 94. While Wnt is critical for muscle development as evident in no dermomyotome formation or Myf5 expression in embryonic Wnt1 and Wnt3a knockout mice, Wnt also contributes postnatal muscle regeneration 90, 93, 98. Activating Wnt signaling by treating myoblasts with lithium chloride (LiCl, which inhibits GSK3ß activity) results in increased MHC and Myogenin expression; and treating myoblasts with Wnt3a results in a ~ 30% increase in Desmin expression 90, 93, 99, 100. Brack et al. 94 reports a ~ 40% increase in muscle regeneration in myogenic cells with forced Wnt expression, further demonstrating that Wnt signaling promotes postnatal muscle repair 94. Wnt's main role during muscle regeneration is myoblast differentiation and myotube fusion 99-103. Premature myogenic differentiation occurs in freeze-injured muscle injected with Wnt3a 93. Furthermore, treatment of proliferation C2C12 myoblasts or single fiber cultures with Wnt antagonists or secreted frizzled receptor proteins (sFRPs) repress myotube formation, decreases Myogenin and Mrf4 RNA expression by ~ 50% as well as inhibits Desmin expression 93, 102. Moreover, there is impaired myotube formation and decreased Myogenin and MHC expressions in siRNA-induced inhibition or knock-out mice of Wnt co-activator BCL9 94. Lastly, there is increased myogenic differentiation in cholesterol depleted- myoblasts identified to promote nuclear translocation of ß-catenin and TCF/LEF activation 103. Myogenesis consists of a series of orchestrated events that require communication of a variety of signaling pathways when transitioning from the phases of satellite cell activation to myoblast proliferation and differentiation and finally, myotube formation. Notch and Wnt interact during muscle development as well as during postnatal myogenesis and it is plausible that this crosstalk contributes to the stage transitions during adult muscle repair 93, 104. It is suggested that Notch activity presides during myoblast proliferation after which there is a temporal switch to Wnt signaling and subsequent myoblast differentiation and fusion into myotubes 93. Inhibiting Notch (with soluble Jagged ligand or with a γ - secretase inhibitor) or activating Wnt (by inhibiting GSK3ß or adding Wnt3a) decreases Myf5 expression and promotes muscle differentiation providing evidence that Notch signaling needs to be turned off and Wnt turned on for differentiation to ensue 93, 100, 103. When Notch inhibitors are administered during the differentiation phase there is no acceleration of muscle regeneration, further supporting the notion that Notch signaling does not participate in the later stages of muscle repair 93. In addition, during the early stages of muscle repair (24 hours) following cardiotoxin-induced muscle injury, Wnt inhibitor, sFRP2 is expressed in proliferating myoblasts and there is no Wnt activity 105; furthermore, administration of Wnt inhibitor, sFRP3 to single-fiber cultures at early stages of muscle repair (day 2 of culture) has no effect on Wnt inhibition but when sFRP3 is added at later time points (day 3.5 of culture), Wnt expression is inhibited and there is less myoblast differentiation. These data suggest that Wnt activity does not occur during the early proliferative stages of muscle repair 93. Brack et al. 93 recommends that low Wnt signaling is needed for a sufficient quantity of proliferating myoblasts prior to myotube formation 93. Notch and Wnt orchestrate together for cell fate decisions in other systems but their roles have not been determined to be similar in the skeletal muscle model 106-108. A co-activation of Notch and Wnt promote proliferation of progenitor intestinal epithelial cells 107. When Notch and Wnt are both active in proliferating progenitor cells within the crypt region of the small intestine, the cells continue to proliferate and form the intestinal absorptive cells called enterocytes 107. In addition, administration of Wnt3a to hematopoietic progenitors cultured in presence of Notch ligand, Delta results in increased Hes1 and CD7+ cells (T cells) suggesting that hematopoietic progenitors cells transform into T cells in the presence of Wnt and Notch 108. Determining if Wnt and Notch regulate each other will aid in delineating the mechanism of orchestration between Notch and Wnt during cell fate determination including postnatal myogenesis. Since Notch appears to dominate during myoblast proliferation and Wnt signaling leads during the differentiation/fusion stages of muscle repair, it is plausible to suggest that Notch signaling is upstream of Wnt. Transfection studies show that the intracellular domain of Notch has binding sites on LEF1 promoter that are different than ß-catenin sites and result in LEF1 transcriptional activation 109. Conversely, it should be noted that there is evidence suggesting Wnt signaling is upstream of Notch 110, 111. The Wnt target genes Brachyury (T-box) and LEF1/TCF1 have binding sites on Notch1 and Delta-like-1 (Dll1) promoter and mice embryos with mutant Tbx6 function (downstream T box target gene) or lacking Brachyury do not express Dll1 110, 111. Furthermore, in the presence of exogenous Wnt3a and Delta1 there is increased Hes1 and Deltex1 expression in hematopoietic stem cells 108, 112. Identifying the location for the point of transition between Notch and Wnt signaling would be beneficial in determining the mechanism of Notch and Wnt orchestration for cell fate decisions including postnatal myogenesis. GSK3ß directly binds to Notch 1 intracellular domain (Notch1IC) and facilitates Notch signaling so it seems plausible that GSK3ß may be a critical juncture between Notch and Wnt pathways during postnatal myogenesis 93, 113, 114. While increased Notch signaling corresponds with elevated GSk3ß activity (GSk3ß phosphorylated at tyrosine 216 GSk3ßpY216) at one day post muscle injury, Wnt contradicts GSk3ß activity and is low at that time point 93. However, as the time course of muscle repair progresses from one day to four days, Wnt signaling increases and both GSK3ß and Notch activity declines 93. Inhibiting GSK3ß activity in mononucleated cells of TOPGAL mice results in increased ß-catenin expression and Wnt reporter activity 93. In addition, treating myoblasts with Notch inhibitor γ-secretase, results in decreased GSK3ß activity 93. These data further confirm the corresponding relationship between GSK3ß and Notch and inverse relationship between GSK3ß and Wnt as well as suggests that GSK3ß activity may be pivotal for the transition between Notch and Wnt signaling. Presenilins, which assist in cleaving full-length Notch to its activated state, have also been suggested to be major players in the coordination of the Notch and Wnt pathways 115, 116. Presenilins have been identified to bind to ß-catenin and possibly participate in ß -catenin ubiquitination115. In addition, there is increased TCF/LEF1 transcription in Presenilin1 knockout embryonic fibroblasts 116. These date suggest that Presenilins may function as mediator between Notch and Wnt by de-regulating Wnt signaling. Besides GSK3ß and Presenilins, there is evidence that Notch antagonist, Numb may be a pivotal point of transition between Notch and Wnt since forced expression of Numb on erythroid progenitor cells treated with exogenous Wnt5a, results in increased TCF/LEF transcriptional activity 106. The orchestration of Notch and Wnt is crucial for cell fate decisions of a variety of tissues. However, there are conflicting reports on the mechanisms of their co-regulation during regenerative processes in skeletal muscle and other tissue models. Of particular interest, is understanding Notch and Wnt's role in satellite cell biology such as regulating myogenic proteins during postnatal myogenesis. What is even less known is the effect of different muscle injury models (including physiological stimuli) in regulating Notch, Wnt and myogenic protein expression during adult muscle repair.

Physiological stimuli and muscle regeneration and growth

The current muscle injury models for examining the roles of Notch and Wnt in satellite cell regulation during postnatal myogenesis consist primarily of artificial techniques which do not consider the influences of other biological systems and are not easily applied to muscle function scenarios. Physiological stimuli such as contraction-induced muscle injury (injurious exercise) and growth models (overload hypertrophy, resistance exercises) are functionally relevant and involve the contribution of multiple active biological systems which are important to consider when investigating sources responsible for muscle regenerative processes. A common injurious exercise model, downhill running (DHR), uses eccentric muscle contractions in which the contracting muscle is forced to lengthen by an external force while producing tension 9, 117-119. DHR in rodents results in decreased isometric force production and elevations in muscle injury makers such as creatine kinase activity and muscle injury criteria identified with Hematoxylin and Eosin staining 118, 120, 121. DHR is also known to stimulate muscle remodeling and myogenesis processes 121-128. DHR induce ~80% up regulation of mitogen-activated protein kinase (MAPK) signaling such as phosphorylation of JNK, p38, and ERK 129. Myogenic markers Myf5, MyoD, Myosin Heavy Chain (MHC), MCadherin, Desmin, and Pax 7 increase expression within the first week following DHR 121-127. There is increased Myf5 transcriptional activity in Myf5LacZ reporter mice at 48 hours to 96 hours post DHR 128. Overall, there is sufficient data to exhibit that DHR induces a myogenic response and may be worthy as a model for studying postnatal myogenesis regulation. One aspect to consider when using the DHR model to study myogenesis is that the time course of muscle repair with the DHR model may be different than with artificial muscle injury models. There is a delay in the onset of muscle regeneration in the DHR model relative to cardiotoxin injections (CTX) 122. Armand et al. 122 reports that CTX-injured soleus fibers exhibit extensive myofiber damage at 24 hours to 72 hours post injury, while DHR-injured fibers are not apparent until 96 hours to 144 hours post exercise. At 120 hours post-CTX, muscle regeneration dominates while signs of muscle repair are not present until 144 hours to 168 hours post-DHR. Although DHR does not induce as profound of muscle injury as seen in the CTX model, this exercise injury model still induces a myogenic response. Besides the DHR model, other eccentric contraction models are available to study muscle regeneration 130-139. Eccentric contractions on an isokinetic dynamometer results in muscle remodeling in the hours to days post exercise including increased expression of hepatocyte growth factor (HGF), MyoD, mechano growth factor, neural cell adhesion molecule, Pax7 and insulin-like growth factor 1 (IGF1) 134-138. In situ muscle lengthening contraction injury model is a physiological test that uses a rigorous and precise control of muscle contraction by electrically stimulating motor neurons of associated muscles of interest 130-132, 139. With its ability to quantify muscle function this biological model offers a unique approach relative to other muscle injury protocol. There is a 70%-80% decrease in isometric force production and a 15- 20% increase in injured fibers in mice EDL at three days following exposure to electrically stimulated lengthening contractions 131. Inflammation is also present at three days post injury with reports of a 7.9 fold and 51.2 fold increase in muscle associated neutrophils and macrophages respectively 140. With the profound magnitude of muscle injury present in this physiological stimulus model as well as the presence of myogenic-associated proteins, it seems plausible that one could use this novel muscle injury model to study the regulation of myogenic repair as it relates to recovery of function. Muscle overload techniques (heavy resistance exercise, stretch hypertrophy and compensatory hypertrophy) are physiological stimuli capable of investigating the contribution of myogenic properties to growth. Overload-induced muscle hypertrophy is a type of a compensatory hypertrophy model in which muscles are ablated (such as the gastrocnemius, soleus or tibialis anterior) and the remaining muscles (such as the plantaris or extensor digitorum longus) work harder to maintain muscle function 141. This compensation of the remaining muscles results in growth including increased DNA synthesis, muscle mass and force production 141-148. Overloaded rat soleus has a 40% increase in wet weight and ~ 6.76% to 12.74% increase in de novo myofibers 142. The cross sectional area of a single myofiber as well as myonuclei number per millimeter of a myofiber increase at 46% and 44% respectively in an overloaded rat plantaris 149. It is suggested that activation of satellite cells is a source of the new myonuclei rather than sole provision from differentiated myotubes 149, 150. Petrella et al. 151 reports that a 117% increase in satellite cells accompanies the 26% increase in myonuclei following heavy resistance exercises 151. During the early hours and within the first week of compensatory overload there is evidence of satellite cell activation and myogenic response including up-regulated Pax 7, M-Cadherin, MyoD, Desmin, Myogenin, MHC as well as fibroblast growth factors 1 and 7, IGF1 and HGF 142, 145, 147, 148, 152-155. The contribution of satellite cells to muscle repair and growth is not conclusive. There is evidence supporting the notion that satellite cells are critical to muscle repair, recovery of muscle function as well as important to muscle growth 142, 149, 156-158. Irradiation-induced inhibition of proliferating myogenic cells results in decreased force recovery following injurious eccentric contractions to rodent anterior crural muscles 156, 157. Non-irradiated mice have complete force recovery at three weeks post exposure to an injurious lengthening protocol while irradiated mice exhibit a 35% force deficit 156. In addition, MyoD and Myogenin transcripts are increased at three, seven, 14, and 21 days post lengthening contractions in non-irradiated mice while irradiated mice do not show any MRF up-regulation 156. There is evidence of the importance of satellite cells in the overload muscle growth models 142, 149. Phelan et al. (1997) reports no hypertrophy following four weeks of overloading in irradiated rat soleus 142. In addition, there is no increase in muscle mass, myofibrillar protein, DNA content, or cross sectional area of a single myofiber at three months following overloading in irradiated rat hindlimb muscle 149. However, it needs to be mentioned that there is data demonstrating the occurrence of muscle hypertrophy without up regulation of myogenic proteins following muscle overload and proponents that propose the critical component for muscle hypertrophy is protein synthesis and not satellite cells 159, 160. Since IGF1 induces muscle hypertrophy by stimulating protein production via signaling pathways such as PI3K/Akt/mTOR/S6K1 161-164 investigators from this camp manipulate IGF to study the impact of protein synthesis on muscle hypertrophy. There is increased muscle hypertrophy in overloaded mice that over-express muscle IGF1 or Akt 165-167. In addition, irradiated mice that are introduced with viral-mediated IGF1 gene transfer have greater muscle growth than with just irradiation alone 162. To add complication to the controversy, it is also proposed that both satellite cells and protein synthesis contribute to muscle repair and hypertrophy 162, 168, 169. Barton Davis et al. 162 identified IGF1 receptors on satellite cells and differentiated muscle fibers 162. They suggest that IGF1 could co-activate satellite cells and adult muscle fibers to induce hypertrophy so that in conditions in which irradiation depletes proliferating activated satellite cells the mature muscle fibers could be responsible for the increased protein synthesis 162. Others suggest that the predominating mechanism of either satellite cell activation or increased protein synthesis may be due to the timeline of events following a hypertrophic stimulus 168, 169. Perhaps “early” hypertrophy is due to increased transcription and translation while hypertrophy that occurs at later time points may be due to increased satellite cell activation, resulting in increased myonuclei number 168, 169. More work is needed to delineate the importance of protein synthesis compared to satellite cells to muscle repair and growth.

The interaction of physiological stimuli, Notch and Wnt, and muscle regeneration

There are still many questions in regards to the contribution of satellite cells to muscle repair and growth. Using “global” forms of muscle injury and growth such as contraction-induced muscle injury models and overload-induced hypertrophy models will help identify whether the basis satellite cell activation is intrinsic, muscle-derived, or arise from other systems (nervous, circulatory, inflammatory, etc…). Furthermore, studying the communication of cell signaling pathways important for muscle regeneration (such as Notch, Wnt) as relates to satellite cell activation will aid in delineating the source of satellite cell activation resulting in determining the importance satellite cells to muscle repair and growth. Research on the interaction of physiological stimuli, Notch and Wnt signaling and muscle repair and growth would aid in furthering the understanding of satellite cell regulation. Physiological stimuli up-regulates components of Notch and Wnt signaling 92, 127, 170-175. DHR increases Notch1 and Delta1 expression in myogenic cells at 72 hours through 120 hours post-injury 127. A single injurious bout of resistance exercise increases Notch1 and downstream regulator Hes6 mRNA 170. Overload-induced hypertrophy also increases Notch1 expression in Pax7-positive myogenic cells 171. In vivo exercise decreases GSK3ß activity and ß-catenin phosphorylation which is required for Wnt signaling activation 173, 174. Overload-induced hypertrophy up-regulates total ß-catenin, receptor Frizzled1, Wnt regulator Disheveled1, Wnt downstream target genes cmyc and Cyclin D1 as well as induce a 434% increase in nuclear ß-catenin and promotion of ß-catenin/LEF1 complex formation 172, 175. There is evidence that ß-catenin may be required for muscle hypertrophy since there is no hypertrophy in overloaded mice with conditional inactivation of ß-catenin 92. There is an abundance of evidence stating that physiological stimuli up-regulates Notch and Wnt signaling but more research is needed on the effect of physiological stimuli on the orchestration and regulation of these signaling pathways during muscle repair.

Conclusion

With the development of tools available to identify satellite cells, it is feasible to study the characterization and regulation of postnatal myogenesis. More work is needed to discern the factor(s) responsible for re-awakening these normally quiescent skeletal muscle stem cells as well as to determine the collaboration of the various signaling mechanisms as relates to regulating the myogenic proteins. Notch and Wnt signaling have recently been identified to be critical to muscle regeneration. The revelation of the importance of Notch and Wnt signaling to during muscle repair is recognized in artificial muscle injury models but is largely unknown in physiological stimuli models. Contracting skeletal muscle releases a plethora of signals that induces autocrine and paracrine effects that may influence the regulation of postnatal myogenesis differently than localized muscle injury models. Therefore, understanding the intrinsic and systemic response of contracting muscle will aid in deciphering the regulation of satellite cells and muscle repair as well as understanding the molecular mechanisms responsible for the beneficial protective effects of exercise to cardiovascular disease and cancer.
  175 in total

Review 1.  Wnt signalling during limb development.

Authors:  Vicki L Church; Philippa Francis-West
Journal:  Int J Dev Biol       Date:  2002       Impact factor: 2.203

2.  Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split.

Authors:  Y Sasai; R Kageyama; Y Tagawa; R Shigemoto; S Nakanishi
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

Review 3.  Acute inflammation: the underlying mechanism in delayed onset muscle soreness?

Authors:  L L Smith
Journal:  Med Sci Sports Exerc       Date:  1991-05       Impact factor: 5.411

4.  Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene.

Authors:  P Hasty; A Bradley; J H Morris; D G Edmondson; J M Venuti; E N Olson; W H Klein
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

5.  Separable regulatory elements governing myogenin transcription in mouse embryogenesis.

Authors:  T C Cheng; M C Wallace; J P Merlie; E N Olson
Journal:  Science       Date:  1993-07-09       Impact factor: 47.728

6.  Myogenin gene disruption results in perinatal lethality because of severe muscle defect.

Authors:  Y Nabeshima; K Hanaoka; M Hayasaka; E Esumi; S Li; I Nonaka; Y Nabeshima
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

7.  MyoD or Myf-5 is required for the formation of skeletal muscle.

Authors:  M A Rudnicki; P N Schnegelsberg; R H Stead; T Braun; H H Arnold; R Jaenisch
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

8.  mdx mice show progressive weakness and muscle deterioration with age.

Authors:  C Pastoret; A Sebille
Journal:  J Neurol Sci       Date:  1995-04       Impact factor: 3.181

9.  Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.

Authors:  A Yamaguchi; T Katagiri; T Ikeda; J M Wozney; V Rosen; E A Wang; A J Kahn; T Suda; S Yoshiki
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

10.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.

Authors:  T Katagiri; A Yamaguchi; M Komaki; E Abe; N Takahashi; T Ikeda; V Rosen; J M Wozney; A Fujisawa-Sehara; T Suda
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  32 in total

1.  Transcriptional profile of GTP-mediated differentiation of C2C12 skeletal muscle cells.

Authors:  Rosa Mancinelli; Tiziana Pietrangelo; Geoffrey Burnstock; Giorgio Fanò; Stefania Fulle
Journal:  Purinergic Signal       Date:  2011-12-01       Impact factor: 3.765

Review 2.  Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions.

Authors:  Vanessa Dubois; Michaël Laurent; Steven Boonen; Dirk Vanderschueren; Frank Claessens
Journal:  Cell Mol Life Sci       Date:  2011-11-19       Impact factor: 9.261

3.  MASTR directs MyoD-dependent satellite cell differentiation during skeletal muscle regeneration.

Authors:  Mayssa H Mokalled; Aaron N Johnson; Esther E Creemers; Eric N Olson
Journal:  Genes Dev       Date:  2012-01-15       Impact factor: 11.361

Review 4.  Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.

Authors:  Pedro Cisternas; Juan P Henriquez; Enrique Brandan; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2013-09-07       Impact factor: 5.590

5.  Degenerative and regenerative features of myofibers differ among skeletal muscles in a murine model of muscular dystrophy.

Authors:  Teppei Ikeda; Osamu Ichii; Saori Otsuka-Kanazawa; Teppei Nakamura; Yaser Hosny Ali Elewa; Yasuhiro Kon
Journal:  J Muscle Res Cell Motil       Date:  2016-07-29       Impact factor: 2.698

Review 6.  Implications of glucocorticoid therapy in idiopathic inflammatory myopathies.

Authors:  Beatriz Y Hanaoka; Charlotte A Peterson; Craig Horbinski; Leslie J Crofford
Journal:  Nat Rev Rheumatol       Date:  2012-06-12       Impact factor: 20.543

7.  Wnt protein-mediated satellite cell conversion in adult and aged mice following voluntary wheel running.

Authors:  Shin Fujimaki; Ryo Hidaka; Makoto Asashima; Tohru Takemasa; Tomoko Kuwabara
Journal:  J Biol Chem       Date:  2014-01-30       Impact factor: 5.157

Review 8.  Notch signaling and cardiac repair.

Authors:  Natalie Gude; Mark Sussman
Journal:  J Mol Cell Cardiol       Date:  2012-03-21       Impact factor: 5.000

9.  Brain and muscle Arnt-like 1 is a key regulator of myogenesis.

Authors:  Somik Chatterjee; Deokhwa Nam; Bingyan Guo; Ji M Kim; Glen E Winnier; Jeongkyung Lee; Rebecca Berdeaux; Vijay K Yechoor; Ke Ma
Journal:  J Cell Sci       Date:  2013-03-22       Impact factor: 5.285

10.  GSK3β inhibition and LEF1 upregulation in skeletal muscle following a bout of downhill running.

Authors:  Hiral Amin; Judy Vachris; Alicia Hamilton; Nury Steuerwald; Reuben Howden; Susan Tsivitse Arthur
Journal:  J Physiol Sci       Date:  2013-08-21       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.